Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia)

Developmental Medicine and Child Neurology

Volumn 44, Issue 10, 2002, Pages 712-720

  Korman, Stanley H ^a   Gutman, Alisa ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BENZOIC ACID; CLONAZEPAM; CORTICOTROPIN; GLYCINE; HYDANTOIN; KETAMINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

AMINO ACID BLOOD LEVEL; AMINO ACID SYNTHESIS; AMINOACIDURIA; ANTICONVULSANT THERAPY; BRAIN DISEASE; CEREBROSPINAL FLUID LEVEL; CONTAMINATION; CONVULSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; DRUG MECHANISM; GENE MUTATION; GLYCINURIA; HUMAN; HYPERGLYCINEMIA; INBORN ERROR OF METABOLISM; KWASHIORKOR; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NONHUMAN; PARENTERAL NUTRITION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN MALNUTRITION; PSYCHOMOTOR DISORDER; RELIABILITY; REVIEW; SEIZURE; STARVATION; TRANSURETHRAL RESECTION; UROLOGIC SURGERY;

ANTICONVULSANTS; BRAIN DISEASES, METABOLIC, INBORN; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CONSANGUINITY; DIAGNOSIS, DIFFERENTIAL; EPILEPSY, TONIC-CLONIC; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GENES, RECESSIVE; GLYCINE; HUMANS; HYPERGLYCINEMIA, NONKETOTIC; INFANT, NEWBORN; NEUROLOGIC EXAMINATION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0036772660     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162201002808     Document Type: Review

References (104)

1. Hamosh A, Johnston MV. (2001) Non-ketotic hyperglycinemia. In: Scriver CR, Beauder AL, Sly WS, Valle D, editors. The Metabolic & Molecular Bases of Inherited Disease. 8th edn. New York: McGraw-Hill. p 2065-78.
2. Tada K, Kure S. (1993) Non-ketotic hyperglycinaemia: molecular lesion, diagnosis, and pathophysiology. Journal of Inherited Metabolic Disease 16: 691-703.
3. Sakata Y, Oawada Y, Sata K, Kojima K, Hisanaga K, Shinka T, Suzuki Y, Aoki Y, Satoh J, Kondo H, Matsubara Y, Kure S. (2001) Structure and expression of the glycine cleavage system in rat central nervous system. Brain Research Molecular Brain Research 94: 119-30.
4. Holmgren G, Blomquist HK. (1977) Non-ketotic hyperglycinemia in two sibs with mild psychoneurological symptoms. Neuropediatrics 8: 67-72.
5. Ando T, Nyhan WL, Bicknell J, Harris R, Stern J. (1978) Journal of Inherited Metabolic Disease 1: 79-83.
6. Frazier DM, Summer GK, Chamberlin HR. (1978) Hyperglycinuria and hyperglycinemia in two siblings with mild developmental delays. American Journal of Diseases of Children 132: 777-81.
7. Steinman GS, Yudkoff M, Berman PH, Blazer-Yost B, Segal S. (1979) Late-onset non-ketotic hyperglycinemia and spinocerebellar degeneration. Journal of Pediatrics 94: 907-11.
8. Trauner DA, Page T, Greco C, Sweetman L, Kulovich S, Nyhan WL. (1981) Progressive neurodegenerative disorder in a patient with non-ketotic hyperglycinemia. Journal of Pediatrics 98: 272-5.
9. Flannery DB, Pellock J, Bousounis D, Hunt P, Nance C, Wolf B. (1983) Non-ketotic hyperglycinemia in two retarded adults: a mild form of infantile non-ketotic hyperglycinemia. Neurology 33: 1064-6.
10. Borrone C, Bachmann C, Di Rocco M, Tada K, Hayasaka K, Gatti R. (1986) Atypical non-ketotic hyperglycinaemia. Journal of Inherited Metabolic Disease 9: 402-3.
11. Haan EA, Kirby DM, Tada K, Hayasaka K, Danks DM. (1986) Difficulties in assessing the effect of strychnine on the outcome of non-ketotic hyperglycinaemia. Observations on sisters with a mild T-protein defect. European Journal of Pediatrics 145: 267-70.
12. Singer HS, Valle D, Hayasaka K, Tada K. (1989) Non-ketotic hyperglycinemia: studies in an atypical variant. Neurology 39: 286-8.
13. Christodoulou J, Kure S, Hayasaka K, Clarke JT. (1993) Atypical non-ketotic hyperglycinemia confirmed by assay of the glycine cleavage system in lymphoblasts. Journal of Pediatrics 123: 100-2.
14. Tanaka Y, Miyazaki M, Tsuda M, Murai K, Kuzuhara S. (1993) Blindness due to non-ketotic hyperglycinemia: report of a 38-year-old - the oldest case to date. Internal Medicine 32: 641-2.
15. Steiner RD, Sweetser DA, Rohrbaugh JR, Dowton SB, Toone JR, Applegarth DA. (1996) Non-ketotic hyperglycinemia: atypical clinical and biochemical manifestations. Journal of Pediatrics 128: 243-6.
16. Wraith JE. (1996) Non-kinetic hyperglycinaemia: prolonged survival in a patient with a mild variant. Journal of Inherited Metabolic Disease 19: 695-6.
17. Jackson AH, Applegarth DA, Toone JR, Kure S, Levy HL. (1999) Atypical non-ketotic hyperglycinemia with normal cerebrospinal fluid to plasma glycine ratio. Journal of Child Neurology 14: 464-7.
18. Wiltshire EJ, Poplawski NK, Harrison JR, Fletcher FM. (2000) Treatment of late-onset non-ketotic hyperglycinaemia: effectiveness of imipramine and benzoate. Journal of Inherited Metabolic Disease 23: 15-21.
19. Neuberger JM, Schweitzer S, Rolland MO, Burghard R. (2000) Effect of sodium benzoate in the treatment of atypical non-ketotic hyperglycinaemia. Journal of Inherited Metabolic Disease 23: 22-6.
20. Cataltepe S, van Marter LJ, Kozakewich H, Wessel DL, Lee PJ, Levy HL. (2000) Pulmonary hypertension associated with non-ketotic hyperglycinaemia. Journal of Inherited Metabolic Disease 23: 137-44.
21. Schiffmann R, Kaye EM, Willis JK, Africk D, Ampola M. (1989) Transient neonatal hyperglycinemia. Annals of Neurology 25: 201-3.
22. Luder AS, Davidson A, Goodman SI, Greene CL. (1989) Transient non-ketotic hyperglycinemia in neonates. Journal of Pediatrics 114: 1013-5.
23. Eyskens FJ, Van Doorn JW, Marien P. (1992) Neurologic sequelae in transient non-ketotic hyperglycinemia of the neonate. Journal of Pediatrics 121: 620-1.
24. Zammarchi E, Donati MA, Ciani F. (1995) Transient neonatal non-ketotic hyperglycinemia: a 13-year follow-up. Neuropediatrics 26: 328-30.
25. Alejo J, Rincon P, Vaquerizo J, Gil C, Plasencia A, Gallardo R. (1997) Case report. Transient non-ketotic hyperglycinaemia: ultrasound, CT, and MRI. Neuroradiology 39: 658-60.
26. Maeda T, Inutsuka M, Goto K, Izumi T. (2000) Transient non-ketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures. Pediatric Neurology 22: 225-7.
27. von Wendt L, Hirvasniemi A, Simila S. (1979) Non-ketotic hyperglycinemia. A genetic study of 13 Finnish families. Clinical Genetics 15: 411-7.
28. Toone JR, Applegarth DA. (1989) Use of placental enzyme analysis in assessment of the newborn at risk for non-ketotic hyperglycinaemia (NKH). Journal of Inherited Metabolic Disease 12: 281-5.
29. Applegarth DA, Toone JR, Lowry RB. (2000) Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics www.pediatrics.org/cgi/content/full/05/1/e10
30. Boneh A, Degani Y, Harari M. (1996) Prognostic clues and outcome of early treatment of non-ketotic hyperglycinemia. Pediatric Neurology 155: 137-41.
31. Kure S, Mandel H, Holland MO, Sakata Y, Shinka T, Drugan A, Boneh A, Tada K, Matsubara Y, Narisawa K. (1998) A missense mutation (His42Arg) in the T-protein gene from a large Israeli-Arab kindred with non-ketotic hyperglycinemia. Human Genetics 102: 430-4.
32. Kure S, Rolland MO, Leisti J, Mandel H, Sakata Y, Tada K, Matsubara Y, Narisawa K. (1999) Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations. Prenatal Diagnosis 19: 717-20.
33. Hayasaka K, Tada K, Kikuchi G, Winter S, Nyhan WL. (1983) Non-ketotic hyperglycinemia: two patients with primary defects of P-protein and T-protein respectively, in the glycine cleavage system. Pediatric Research 17: 967-70.
34. Kure S, Narisawa K, Tada K. (1992) Enzymatic diagnosis of non-ketotic hyperglycinemia with lymphoblasts. Journal of Pediatrics 120: 95-8.
35. Applegarth DA, Toone JR. (2001) Non-ketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis. Molecular Genetics and Metabolism 74: 139-46
36. Kure S, Takayanagi M, Narisawa K,Tada K, Leisti J. (1992) Identification of a common mutation in Finnish patients with non-ketotic hyperglycinemia. Journal of Clinical Investigation 90: 160-4.
37. Toone JR, Applegarth DA, Coulter-Mackie MB, James ER. (2000) Biochemical and molecular investigations of patients with non-ketotic hyperglycinemia. Molecular Genetics and Metabolism 70: 116-21.
38. Toone JR, Applegarth DA, Coulter-Mackie MB, James ER. (2001) Identification of the first reported splice site mutation (IVS7-1G-A) in the aminomethyltransferase (T-protein) gene (AMT) of the glycine cleavage. complex in 3 unrelated families with non-ketotic hyperglycinemia. Human Mutatation 17: 76.
39. Toone JR, Applegarth DA, Coulter-Mackie MB, James ER. (2001) Recurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N145I): a strategy for the molecular in investigation of patients with non-ketotic hyperglycinemia (NKH). Molecular Genetics and Metabolism 72: 322-5.
40. Kure S, Kojima K, Kudo T, Kanno K, Aoki Y, Suzuki Y, Shinka T, Sakata Y, Narisawa K, Matsubara Y. (2001) Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for non-ketotic hyperglycinemia. Journal of Human Genetics 46: 378-84.
41. Isobe M, Koyata H, Sakakibara T, Momoi-Isobe K, Hiraga K. (1994) Assignment of the true and processed genes for human glycine decarboxylase to 9p23-24 and 4q12. Biochemical and Biophysical Research Communications 30: 1483-7.
42. Takayanagi M, Kure S, Sakata Y, Kurihara Y, Ohya Y, Kajita M, Tada K, Matsubara Y, Narisawa K. (2000) Human glycine decarboxylase gene (GLDC) and its highly conserved processed pseudogene (psiGLDC): their structure and expression, and the identification of a large deletion in a family with non-ketotic hyperglycinemia. Human Genetics 106: 298-305.
43. Randak C, Rosschinger W, Rolinski B, Hadorn HB, Applegarth DA, Roscher AA. (2000) Three siblings with non-ketotic hyperglycinaemia, mildly elevated plasma homocysteine concentrations, and moderate methylmalonic aciduria. Journal of Inherited Metabolic Disease 23: 520-2.
44. Kolvraa S. (1979) Inhibition of the glycine cleavage system by branched-chain amino acid metabolites. Pediatric Research 18: 889-93.
45. Hayasaka K, Narisawa K, Satoh T, Tateda H, Metoki K. Tada K, Hiraga K, Aoki T, Kawakami T, Akamatsu H, Matsuo N. (1982) Glycine cleavage system in ketotic hyperglycinemia: a reduction of H-protein activity. Pediatric Research 16: 5-7.
46. Hayasaka K, Tada K. (1983) Effects of the metabolites of the branched-chain amino acids and cysteamine on the glycine cleavage system. Biochemistry International 6: 225-30.
47. Brandt NJ, Brandt S, Rasmussen K, Schonheyder F. (1994) Hyperglyceric-acidaemia with hyperglycinaemia: a new inborn error of metabolism. British Medical Journal 4: 344. (Letter).
48. Wadman SK, Duran M, Ketting D, Bruinvis L, De Bree PK, Kamerling JP, Gerwig GJ, Vliegenthart JF, Przyrembel H, Becker K, Bremer HJ. (1976) D-glyceric acidemia in a patient with chronic metabolic acidosis. Clinica Chimica Acta 71: 477-84.
49. Grandgeorge D, Favier A, Bost M, Frappat P, Boujet C, Garrel S, Stoebner P. (1994) L'acidémie D-glycérique. A propos d'une nouvelle observation anatomo-clinique. Archives Francaises de Pediatrie 37: 577-84. (In French).
50. Duran M, Beemer FA, Bruinvis L, Ketting D, Wadman SK. (1987) D-glyceric acidemia: an inborn error associated with fructose metabolism. Pediatric Research 21: 502-6.
51. Fontaine M, Porchet N, Largillière C, Marrakchi S, Lhermitte M, Aubert JP, Degand P. (1989) Biochemical contribution to diagnosis and study of a new case of D-glyceric acidemia/aciduria. Clinical Chemistry 35: 2148-51.
52. Bonham JR, Stephenson TJ, Carpenter KH, Rattenbury JM, Cromby CH, Pollitt RH, Hull D. (1990) D(+)-glyceric aciduria: etiology and clinical consequences. Pediatric Research 28: 38-41.
53. Sewell AC, Moritz A, Duran M. (1997) D-(+)-Glyceric aciduria in an Afghan hound. Journal of Inherited Metabolic Disease 20: 395-6.
54. Kolvraa S, Rasmussen K, Brandt NJ. (1976) D-glyceric acidemia: biochemical studies of a new syndrome. Pediatric Research 10: 825-30.
55. Van Schaftingen E. (1989) D-glycerate kinase deficiency as a cause of D-glyceric aciduria. FEBS Letters 243: 127-31.
56. Largillière C, Fontaine M, Jakobs C, Lemaitre JF. (1992) D-glyceric aciduria: new development. Journal of Inherited Metabolic Disease 15: 942.
57. Brandt NJ, Rasmussen K, Brandt S, Kolvraa S, Schonheyder F. (1976) D-glyceric-acidaemia and non-ketotic hyperglycinaemia. Clinical and laboratory findings in a new syndrome. Acta Paediatrica Scandinavica 65: 17-22.
58. Kolvraa S, Christensen E, Brandt NJ. (1980) Studies of the glycine metabolism in a patient with D-glyceric acidemia and hyperglycinemia. Pediatric Research 14: 1029-34.
59. Brandt NJ, Christensen E, Kolvraa S, Rasmussen K. (1977) D-glyceric-acidaemia in non-ketotic hyperglycinaemia: a new inborn error of metabolism. Annals of Clinical Biochemistry 14: 142-4.
60. Kolvraa S, Gregersen N, Brandt NJ. (1980) Excretion of short-chain N-acylglycines in the urine of a patient with D-glyceric acidemia. Clinica Chimica Acta 106: 215-21.
61. Kolvraa S, Rosleff F, Brandt NJ. (1983) Normal glycine transport in cultured diploid fibroblasts from hyperglycinaemic subjects. Journal of Inherited Metabolic Disease 6: 82-4.
62. Kolvraa S, Gregersen N, Christensen E. (1984) In vivo studies on the metabolic derangement in a patient with D-glyceric acidaemia and hyperglycinaemia. Journal of Inherited Metabolic Disease 7: 49-52.
63. Subhedar NV, Isherwood DM, Davidson DC. (1996) Hyperglycinaemia in a child with carbohydrate-deficient glycoprotein syndrome type I. Journal of Inherited Metabolic Disease 19: 796-7.
64. Jaeken J. Stibler H. (1989) A newly recognized inherited neurological disease with carbohydrate-deficient secretory glycoproteins. In: Wetterberg L, editor. Genetics of Neuropsychiatric Diseases. Wenner-Gren Center International Symposium Series. Vol. 51. New York: Macmillan. p 69-80.
65. Pavone L, Mollica F, Levy HL. (1997) Asymptomatic type II hyperprolinaemia associated with hyperglycinaemia in three sibs. Archives of Disease in Childhood 50: 637-41.
66. Holt LE Jr, Snyderman SE, Norton PM, Roitman E, Finch J. (1963) The plasma aminogram in kwashiorkor. Lancet 2: 1343-8.
67. Felig P, Owen OE, Wahren J, Cahill GF Jr. (1969) Amino acid metabolism during prolonged starvation. Journal of Clinical Investigation 48: 584-94.
68. Applegarth DA, Poon S. (1975) Interpretation of elevated blood glycine levels in children. Clinica Chimica Acta 63: 49-54.
69. Jaeken J, Corbeel L, Casaer P, Carchon H, Eggermont E, Eeckels R. (1977) Dipropylacetate (valproate) and glycine metabolism. Lancet 2: 617. (Letter).
70. Simila S, von Wendt L, Linna SL, Saukkonen AL, Huhtaniemi I. (1979) Dipropylacetate and hyperglycinemia. Neuropadiatrie 10: 158-60.
71. Mortensen PB, Kolvraa S, Christensen E. (1980) Inhibition of the glycine cleavage system: hyperglycinemia and hyperglycinuria caused by valproic acid. Epilepsia 21: 563-9.
72. Ciani F, Pasquini E, Ciardetti A, Donati MA, Zammarchi E. (1997) Hyperglycinemia in clinical-laboratory practice. La Pediatria Medica e Chirurgica 19: 109-12.
73. Iinuma K, Hayasaka K, Narisawa K, Tada K, Hori K. (1988) Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid. European Journal of Pediatrics 148: 267-9.
74. Kochi H, Hayasaka K, Hiraga K, Kikuchi G. (1979) Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia. Archives of Biochemistry & Biophysics 198: 589-97.
75. Martin-Gallardo A, Rodriguez P, Lopez M, Benavides J, Ugarte M. (1985) Effects of dipropylacetate on the glycine cleavage enzyme system and glycine levels. A possible experimental approach to non-ketotic hyperglycinemia. Biochemical Pharmacology 34: 2877-82.
76. Cherruau B, Mangeot M, Demelier JF, Charpentier C, Pelletier C, Lemonnier A. (1981) Metabolic abnormalities observed in the rat after administration of sodium dipropylacetate. Toxicology Letters 8: 39-42.
77. Hahn RG. (1997) Irrigating fluids in endoscopic surgery. British Journal Urology 79: 669-80.
78. Parvy P, Bardet J, Rabier D, Nedellec J, Kamoun P. (1991) A false hyperglycinaemia. Journal of Inherited Metabolic Disease 14: 112.
79. Perry TL, Urquhart N, MacLean J, Evans ME, Hansen S, Davidson GF, Applegarth DA, MacLeod PJ, Lock JE. (1975) Non-ketotic hyperglycinemia. Glycine accumulation due to absence of glycine cleavage in brain. New England Journal of Medicine 292: 1269-73.
80. Ruppel RA, Kochanek PM, Adelson PD, Rose ME, Wisniewski SR, Bell MJ, Clark RS, Marion DW, Graham SH. (2001) Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. Journal of Pediatrics 138: 18-25.
81. Roldan A, Figueras-Aloy J, Deulofeu R, Jimenez R. (1999) Glycine and other neurotransmitter amino acids in cerebrospinal fluid in perinatal asphyxia and neonatal hypoxic-ischaemic encephalopathy. Acta Paediatrica 88: 1137-41.
82. Biasioli S, D'Andrea G, Feriani M, Chiaramonte S, Fabrias A, Ronco C, La Greca G. (1986) Uremic encephalopathy: an updating. Clinical Nephrology 25: 57-6.
83. van der Knaap MS, Wevers RA, Kure S, Gabreels FJ, Verhoeven NM, van Raaij-Selten B, Jaeken J. (1999) Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. Journal of Child Neurology 14: 728-31.
84. Leegwater PAJ, Vermeulen G, Könst AAM, Naidu S, Mulders J, Visser A, Kersberger P, Mobach D, Fonds D, van Berkel CGM, Lemmers RJLF, Frants RR, Oudejans CBM, Schutgens RBH, Pronk JC, van der Knapp MS. (2001) Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nature Genetics 29: 383-8.
85. Kalviainen R, Halonen T, Pitkanen A, Riekkinen PJ. (1993) Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies. Journal of Neurochemistry 60: 1244-50.
86. Halonen T, Lehtinen M, Pitkanen A, Ylinen A, Riekkinen PJ. (1988) Inhibitory and excitatory amino acids in CSF of patients suffering from complex partial seizures during chronic treatment with gamma-vinyl GABA (vigabatrin). Epilepsy Research 2: 246-52.
87. Pitkanen A, Matilainen R, Ruutiainen T, Lehtinen M, Riekkinen P. (1988) Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients. Journal of Neurology, Neurosurgery & Psychiatry 51: 1395-400.
88. Perry TL, Hansen S, Kennedy J. (1975) CSF amino acids and plasma-CSF amino acid ratios in adults. Journal of Neurochemistry 24: 587-58.
89. Patten BM. (1968) How much blood makes CSF fluid bloody? Journal of the American Medical Association 206: 378 (Letter).
90. Kornhuber ME, Kornhuber J, Kornhuber AW, Hartmann GM. (1986) Positive correlation between contamination by blood and amino acid levels in cerebrospinal fluid of the rat. Neuroscience Letters 69: 212-5.
91. Phang JM, Hu CA, Valle D. (2001) Disorders of proline and hydroxyproline metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic & Molecular Bases of Inherited Disease. 8th edn. New York: McGraw-Hill. p 1821-38.
92. Chesney RW. (2001) Iminoglycinuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic & Molecular Bases of Inherited Disease. 8th edn. New York: McGraw-Hill. p 4971-81.
93. Greene ML, Lietman PS, Rosenberg LE, Seegmiller JE. (1973) Familial hyperglycinuria. New defect in renal tubular transport of glycine and imino acids. American Journal of Medicine 54: 265-71.
94. Oberiter V, Puretic Z, Fabecic-Sabadi V. (1978) Hyperglycinuria with nephrolithiasis. European Journal of Pediatrics 127: 279-85.
95. Käser H, Cottier P, Antener I. (1962) Glucoglycinuria, a new familial syndrome. Journal of Pediatrics 61: 386-394.
96. Garcia-Castro JM, Isales-Forsythe CM, Levy HL, Shih VE, Lao-Velez CR, Gonzalez-Rios MD, Reyes de Torres LC. (1982) Prenatal diagnosis of non-ketotic hyperglycinemia. New England Journal of Medicine 306: 79-81.
97. Mesavage C, Nance CS, Flannery DB, Weiner DL, Suchy SF, Wolf B. (1983) Glycine/serine ratios in amniotic fluid: an unreliable indicator for the prenatal diagnosis of non-ketotic hyperglycinemia. Clinical Genetics 23: 354-8.
98. Toone JR, Applegarth DA, Levy HL. (1994) Prenatal diagnosis of non-ketotic hyperglycinaemia: experience in 50 at-risk pregnancies. Journal of Inherited Metabolic Disease 17: 342-4.
99. Hayasaka K, Tada K, Fueki N, Aikawa J. (1990) Prenatal diagnosis of non-ketotic hyperglycinemia: enzymatic analysis of the glycine cleavage system in chorionic villi. Journal of Pediatrics 116: 444-5.
100. Applegarth DA, Toone JR, Rolland MO, Black SH, Yim DK, Bemis G. (2000) Non-concordance of CVS and liver glycine cleavage enzyme in three families with non-ketotic hyperglycinaemia (NKH) leading to false negative prenatal diagnoses. Prenatal Diagnosis 20: 367-70.
101. Hayasaka K, Tada K, Fueki N, Nakamura Y, Nyhan WL, Schmidt K, Packman S, Seashore MR, Haan E, Danks DM, Schutgens RBH. (1987) Non-ketotic hyperglycinemia: analyses of glycine cleavage system in typical and atypical cases. Journal of Pediatrics 110: 873-7.
102. Nanao K, Okamura-Ikeda K, Motokawa Y, Danks DM, Baumgartner ER, Takada G, Hayasaka K. (1994) Identification of the mutations in the T-protein gene causing typical and atypical non-ketotic hyperglycinemia. Human Genetics 93: 655-8.
103. Brandt NJ, Christensen E. (1984) Omega-aminoaciduria induced by gamma-vinyl GABA. Lancet 1: 450-1.
104. Vallat C, Rivier F, Bellet H, Magnan de Bornier B, Mion H, Echenne B. (1996) Treatment with vigabatrin may mimic alpha-aminoadipic aciduria. Epilepsia 37: 803-5.